Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
1 other identifier
interventional
9
1 country
1
Brief Summary
The purpose of this study is to examine the efficacy of exercise in comparison to wellness education to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition, the two strategies (i.e., exercise and wellness education) will be compared in terms of improvements in sleep as well as levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptom PTSD improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2010
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 8, 2010
CompletedFirst Posted
Study publicly available on registry
September 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedDecember 10, 2014
December 1, 2014
2.9 years
September 8, 2010
December 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD Symptoms
Self-report measure that assesses PTSD Symptoms. Will be assessed at each visit throughout the 3 month protocol.
3 months
Secondary Outcomes (3)
Sleep Quality
3 months
BDNF (by blood sample)
3 months
General Mood and Anxiety Symptoms
3 months
Study Arms (2)
Prolonged Exposure + Exercise
EXPERIMENTALProlonged Exposure + Wellness Intervention
ACTIVE COMPARATORInterventions
75-90 minute weekly psychotherapy sessions x 12 weeks, focused on gradually confronting distressing trauma-related memories and reminders
30 minutes of moderate-intensity treadmill exercise prior to the Prolonged Exposure
30 minutes of wellness education prior to Prolonged Exposure
Eligibility Criteria
You may qualify if:
- You have PTSD
- You are between the age of 18 and 54 if female or between ages 18 and 44 if male.
- You have written physician approval/medical clearance to participate in an exercise protocol.
- Are currently taking no psychotropic medications or are able and willing to discontinue these medications prior to the first PE session.
You may not qualify if:
- You are currently participating in a structured exercise program
- You have severe depression
- You have any history of bipolar disorder, psychotic disorder, or obsessive compulsive disorder;
- You have a diagnosis of eating disorder, or substance abuse or dependence (excluding nicotine) within the past six months
- You have any history of a suicide attempt, or are at significant risk of self-harm or harm to others
- You have ever been diagnosed with organic brain syndrome, mental retardation, or other cognitive dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southern Methodist University
Dallas, Texas, 75206, United States
Related Publications (1)
Powers MB, Medina JL, Burns S, Kauffman BY, Monfils M, Asmundson GJ, Diamond A, McIntyre C, Smits JA. Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. Epub 2015 Feb 23.
PMID: 25706090DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 8, 2010
First Posted
September 10, 2010
Study Start
September 1, 2010
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
December 10, 2014
Record last verified: 2014-12